Adropin acts as an energy regulator through lipid and glucose metabolism [1,2]. This 76 amino acid protein encoded by the ENHO (Energy Homeostasis Associated Gene) gene is primarily expressed in the liver and the central nervous system. Therefore, adropin was also detected in muscle, heart, pancreas, and kidneys [1,2]. Adropin is associated with carbohydrate-lipid metabolism, metabolic diseases [2–5], endothelial function [6] and cardiovascular disease [3–7]. Additionally, Aydin et al. reported that adropin is produced locally in the glomerulus, peritubular interstitial cells, and peritubular capillary endothelial cells of the rat kidneys [4].
